Schaeffer's Options Center
Sponsored by:
Schaeffer's Daily Option Blog

by 3/14/2001 1:40 PM
Stocks quoted in this article:
Talbot's (TLB 43.80) is an upscale women's clothier. This morning before the open, the retailer announced fourth-quarter earnings of 51 cents per share, eking past analysts' estimates by a penny. Same-store sales for the reporting period climbed 12.8 percent. TLB officials also announced plans to buy back around $100 million in stock.

TLB is nevertheless trading lower amid a floundering broader market. In early-afternoon activity, the stock was trading off nearly two percent. Since June, the shares have been in a sideways range, hovering between the 24 and 30 levels.
permalink


by 3/14/2001 11:25 AM
Stocks quoted in this article:
Siemens AG (SI 105.38) manufactures a wide range of industrial and consumer products from traffic control systems to locomotives. The company is additionally involved in communications, computers, household appliances, medical equipment and electrical components.

As of this past Monday, you can add another feather in the cap of Siemens. It began trading on the New York Stock Exchange under the ticker symbol SI. The stock trades as an American Depositary Receipt (ADR), and one ADR represents one share of stock. Prior to the move, the shares could be traded over the counter under the symbol SMAWY US.

Currently there are no options trading on the stock and it does not appear to be marginable at this time.

The Street is watching the stock, as 37 analysts have "buy" or better ratings on it. There are also 18 "holds," as well as an unusual six "sell" ratings.

On its first day of listed trading, the stock traded as high as 113.20 before closing at its low of the day at 110.00. So far this week, the shares have been tracking lower with today's intraday low pegged at 103.10.
permalink


by 3/14/2001 10:45 AM
Stocks quoted in this article:
Biomed (BMET 40-1/2) reported third-quarter earnings this morning of 31 cents per share, beating Street estimates by a penny. The company cited strong sales gains for their medical product lines for their 23 percent growth from level for the same period a year ago. The stock is presently fighting resistance in the form of its 10-day moving average
permalink

by 3/14/2001 10:26 AM
Stocks quoted in this article:
A federal judge ruled in favor of Mylan Laboratories (MYL 22.48), allowing them to sell a generic, cheaper version of BuSpar. An anti-anxiety drug produced by Bristol-Myers Squibb (BMY 59.78), BuSpar is the fifth-best selling drug for BMY. The ruling is expected to a have a negative impact on BuSpar sales. BMY is currently reviewing the judge's decision and considering all options, including an appeal.

BMY is sinking further beneath its 10-day and 20-day moving average and has broken through critical support at the 60 level. This area provided support to the stock at the beginning of 1999 and again in October and November of last year.
permalink


by 3/14/2001 10:15 AM
Stocks quoted in this article:
Analysts are cutting estimates for Compaq Computer (CPQ 18.80), although the company has not lowered its guidance. Citing a general weakness in the computer market, the consensus for CPQ seems to be falling from 20 to 17 cents profit for this quarter. CPQ still estimates a profit of about 21 cents, however, all of its competitors in the same marketplace have reduced their expectations.

A newly-compile report of server sales shows an increase for the fourth quarter. CPQ had strong sales at the low-end of the market, while IBM (IBM 97.56) retained its status as top dog. Sun Microsystems (SUNW 18-13/16) came on as a strong second to IBM with growth in many areas. The market research data shows 14 percent growth in server factory revenues for the quarter.
permalink


Featured Brokers
ADVERTISEMENT
Unusual Option Volume
Option Flow
ADVERTISEMENT
ADVERTISEMENT
Most Active Stocks
Most Active Option Strikes
Largest Open Interest

Partner Center

© 2015 Schaeffer's Investment Research, Inc. 5151 Pfeiffer Road, Suite 250, Cincinnati, Ohio 45242 Phone: (800) 448-2080 FAX: (513) 589-3810 Int'l Callers: (513) 589-3800 Email: service@sir-inc.com

All Rights Reserved. Unauthorized reproduction of any SIR publication is strictly prohibited.

Market Data provided by QuoteMedia.com | Data delayed 15-20 minutes unless otherwise indicated.